HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pneumococcal Surface Protein A does not affect the immune responses to a combined diphtheria tetanus and pertussis vaccine in mice.

Abstract
The Pneumococcal Surface Protein A (PspA) is a promising candidate for the composition of a protein vaccine against Streptococcus pneumoniae. We have previously shown that the whole cell Bordetella pertussis vaccine (wP) is a good adjuvant to PspA, inducing protective responses against pneumococcal infection in mice. In Brazil, wP is administered to children, formulated with diphtheria and tetanus toxoids (DTPw) and aluminum hydroxide (alum) as adjuvant. A single subcutaneous dose of PspA5-DTPlow (a formulation containing PspA from clade 5 and a new generation DTPw, containing low levels of B. pertussis LPS and Alum) induced high levels of systemic anti-PspA5 antibodies in mice and conferred protection against respiratory lethal challenges with two different pneumococcal strains. Here we evaluate the mucosal immune responses against PspA5 as well as the immune responses against the DTP antigens in mice vaccinated with PspA5-DTPlow. Subcutaneous immunization of mice with PspA5-DTPlow induced high levels of anti-PspA5 IgG in the airways but no IgA. In addition, no differences in the influx of cells to the respiratory mucosa, after the challenge, were observed in vaccinated mice, when compared with control mice. The levels of circulating anti-pertussis, -tetanus and -diphtheria antibodies were equivalent in mice vaccinated with DTPlow or PspA5-DTPlow. Antibodies induced by DTPlow or PspA5-DTPlow showed similar ability to neutralize the cytotoxic effects of the diphtheria toxin on Vero cells. Furthermore, combination with PspA5 did not affect protection against B. pertussis and tetanus toxin challenges in mice. Our results support the proposal for a combined PspA-DTP vaccine.
AuthorsFernanda A Lima, Eliane N Miyaji, Wagner Quintilio, Isaias Raw, Paulo L Ho, Maria Leonor S Oliveira
JournalVaccine (Vaccine) Vol. 31 Issue 20 Pg. 2465-70 (May 07 2013) ISSN: 1873-2518 [Electronic] Netherlands
PMID23541622 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 Elsevier Ltd. All rights reserved.
Chemical References
  • Alum Compounds
  • Antibodies, Bacterial
  • Bacterial Proteins
  • Diphtheria Toxin
  • Diphtheria-Tetanus-Pertussis Vaccine
  • Immunoglobulin G
  • Lipopolysaccharides
  • Pneumococcal Vaccines
  • Tetanus Toxin
  • pneumococcal surface protein A
  • aluminum sulfate
  • Pertussis Toxin
Topics
  • Alum Compounds
  • Animals
  • Antibodies, Bacterial (analysis, blood, immunology)
  • Bacterial Proteins (administration & dosage, immunology)
  • Bordetella pertussis (immunology)
  • Chlorocebus aethiops
  • Diphtheria Toxin (antagonists & inhibitors, immunology)
  • Diphtheria-Tetanus-Pertussis Vaccine (immunology)
  • Female
  • Immunity, Mucosal (immunology)
  • Immunoglobulin G (analysis, blood, immunology)
  • Injections, Subcutaneous
  • Lipopolysaccharides (immunology)
  • Mice
  • Mice, Inbred BALB C
  • Pertussis Toxin (antagonists & inhibitors, immunology)
  • Pneumococcal Infections (immunology, prevention & control)
  • Pneumococcal Vaccines (administration & dosage, immunology)
  • Respiratory Mucosa (immunology)
  • Streptococcus pneumoniae (immunology)
  • Tetanus Toxin (antagonists & inhibitors, immunology)
  • Vaccination
  • Vero Cells

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: